3′ end mRNA processing: molecular mechanisms and implications for health and disease

Recent advances in the understanding of the molecular mechanism of mRNA 3′ end processing have uncovered a previously unanticipated integrated network of transcriptional and RNA‐processing mechanisms. A variety of human diseases impressively reflect the importance of the precision of the complex 3′ end‐processing machinery and gene specific deregulation of 3′ end processing can result from mutations of RNA sequence elements that bind key specific processing factors. Interestingly, more general deregulation of 3′ end processing can be caused either by mutations of these processing factors or by the disturbance of the well‐coordinated equilibrium between these factors. From a medical perspective, both loss of function and gain of function can be functionally relevant, and an increasing number of different disease entities exemplifies that inappropriate 3′ end formation of human mRNAs can have a tremendous impact on health and disease. Here, we review the mechanistic hallmarks of mRNA 3′ end processing, highlight the medical relevance of deregulation of this important step of mRNA maturation and illustrate the implications for diagnostic and therapeutic strategies.

[1]  W. Boelens,et al.  The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase , 1994, Cell.

[2]  C. Prives,et al.  Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non‐consensus sites , 1998, The EMBO journal.

[3]  J. Steitz,et al.  Association with terminal exons in pre-mRNAs: a new role for the U1 snRNP? , 1993, Genes & development.

[4]  K. Lindblad-Toh,et al.  Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.

[5]  Z. Dominski,et al.  The Polyadenylation Factor CPSF-73 Is Involved in Histone-Pre-mRNA Processing , 2005, Cell.

[6]  T. Maniatis,et al.  An extensive network of coupling among gene expression machines , 2002, Nature.

[7]  Jing Zhao,et al.  Formation of mRNA 3′ Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis , 1999, Microbiology and Molecular Biology Reviews.

[8]  D. Cooper,et al.  A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview , 2006, Human Genetics.

[9]  J. Manley,et al.  Cotranscriptional processes and their influence on genome stability. , 2006, Genes & development.

[10]  J. Manley,et al.  Mechanism and regulation of mRNA polyadenylation. , 1997, Genes & development.

[11]  D. Black Protein Diversity from Alternative Splicing A Challenge for Bioinformatics and Post-Genome Biology , 2000, Cell.

[12]  D. Shutt,et al.  Functional Coupling of Cleavage and Polyadenylation with Transcription of mRNA* , 2005, Journal of Biological Chemistry.

[13]  G. Luo,et al.  A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators. , 2006, Molecular biology of the cell.

[14]  Bin Tian,et al.  A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.

[15]  M. Losekoot,et al.  A novel polyadenylation signal mutation in the alpha 2-globin gene causing alpha thalassaemia. , 1994, British Journal of Haematology.

[16]  J. Wilusz,et al.  Cleavage site determinants in the mammalian polyadenylation signal. , 1995, Nucleic acids research.

[17]  A. Ristimäki,et al.  Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. , 1996, The Biochemical journal.

[18]  M. Rosbash,et al.  Nuclear RNA export. , 1998, Genes & development.

[19]  H. Kazazian,et al.  Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Cox,et al.  Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer , 2004, British Journal of Cancer.

[21]  G. Gilmartin Eukaryotic mRNA 3' processing: a common means to different ends. , 2005, Genes & development.

[22]  R. Krug,et al.  Crucial role of CA cleavage sites in the cap‐snatching mechanism for initiating viral mRNA synthesis , 2003, The EMBO journal.

[23]  H. Lou,et al.  Alternative RNA processing--its role in regulating expression of calcitonin/calcitonin gene-related peptide. , 1998, The Journal of endocrinology.

[24]  Nick Proudfoot,et al.  New perspectives on connecting messenger RNA 3' end formation to transcription. , 2004, Current opinion in cell biology.

[25]  M. Hentze,et al.  3′ End Processing of the Prothrombin mRNA in Thrombophilia , 2006, Acta Haematologica.

[26]  R. Krug,et al.  Influenza A virus NS1 protein targetspoly(A)‐binding protein II of the cellular 3′‐end processing machinery , 1999, The EMBO journal.

[27]  N. Bazan,et al.  Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic alzheimer neocortex , 1997, Journal of neuroscience research.

[28]  P. Bork,et al.  Splicing factors stimulate polyadenylation via USEs at non‐canonical 3′ end formation signals , 2007, The EMBO journal.

[29]  G. Pangalis,et al.  Polyadenylic acid polymerase activity in normal and leukemic human leukocytes. , 1984, Cancer research.

[30]  K. Murthy,et al.  The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3'-end formation. , 1995, Genes & development.

[31]  J. Manley,et al.  The BARD1-CstF-50 Interaction Links mRNA 3′ End Formation to DNA Damage and Tumor Suppression , 2001, Cell.

[32]  J. Rogers,et al.  Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways , 1980, Cell.

[33]  A. Phelan,et al.  Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing , 1992, Journal of virology.

[34]  M. Akısü,et al.  Effect of Dietary n–3 Fatty Acids on Hypoxia-Induced Necrotizing Enterocolitis in Young Mice , 1998, Neonatology.

[35]  S. Cohen,et al.  Mixed Messages in Early Development , 2006, Science.

[36]  C. P. Morris,et al.  Importance of the glycosylation and polyadenylation variants in metachromatic leukodystrophy pseudodeficiency phenotype. , 1998, Human molecular genetics.

[37]  Hanno Langen,et al.  Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3' end processing and splicing. , 2006, Molecular cell.

[38]  T. Maniatis,et al.  Amplification and characterization of a β-globin gene synthesized in vitro , 1976, Cell.

[39]  J. Tam,et al.  A novel function for the U2AF 65 splicing factor in promoting pre‐mRNA 3′‐end processing , 2002, EMBO reports.

[40]  O. Rozenblatt-Rosen,et al.  The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination. , 2007, Genes & development.

[41]  K. Murthy,et al.  Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro. , 1996, Genes & development.

[42]  Richard Treisman,et al.  Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences , 1988, Nature.

[43]  J. Manley,et al.  RNA polymerase II is an essential mRNA polyadenylation factor , 1998, Nature.

[44]  S. Buratowski,et al.  Connections between mRNA 3' end processing and transcription termination. , 2005, Current opinion in cell biology.

[45]  B. Graveley,et al.  RNA structure is a critical determinant of poly(A) site recognition by cleavage and polyadenylation specificity factor , 1996, Molecular and cellular biology.

[46]  M. Edmonds,et al.  A history of poly A sequences: from formation to factors to function. , 2002, Progress in nucleic acid research and molecular biology.

[47]  R. Duronio,et al.  Histone mRNA expression: multiple levels of cell cycle regulation and important developmental consequences. , 2002, Current opinion in cell biology.

[48]  W. Keller,et al.  Last but not least: regulated poly(A) tail formation. , 1999 .

[49]  D. Cooper,et al.  A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants , 2006, Human Genetics.

[50]  M. Rosbash,et al.  The yeast splicing factor Mud13p is a commitment complex component and corresponds to CBP20, the small subunit of the nuclear cap-binding complex. , 1996, Genes & development.

[51]  M. Losekoot,et al.  A novel polyadenylation signal mutation in the α2‐globin gene causing α thalassaemia , 1994 .

[52]  D. Price,et al.  Cotranscriptional Processing of Drosophila Histone mRNAs , 2003, Molecular and Cellular Biology.

[53]  M. Hentze,et al.  The prothrombin 20209 C→T mutation in Jewish‐Moroccan Caucasians: molecular analysis of gain‐of‐function of 3′ end processing , 2006, Journal of thrombosis and haemostasis : JTH.

[54]  A. Kerstan,et al.  Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. , 1999, Immunity.

[55]  J. Hirsh,et al.  How we diagnose and treat deep vein thrombosis. , 2002, Blood.

[56]  R. Krug,et al.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.

[57]  J. Manley,et al.  Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms , 1996, Molecular and cellular biology.

[58]  S. Buratowski,et al.  Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. , 2004, Molecular cell.

[59]  P. Strisciuglio,et al.  A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency , 2003, Journal of medical genetics.

[60]  J. Alwine,et al.  The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Manley,et al.  Identification and Functional Characterization of Neo-Poly(A) Polymerase, an RNA Processing Enzyme Overexpressed in Human Tumors , 2022 .

[62]  J. Bonner,et al.  Differentiation , 1968, Nature.

[63]  K. Tokunaga,et al.  Polymorphisms of human CD19 gene: possible association with susceptibility to systemic lupus erythematosus in Japanese , 2002, Genes and Immunity.

[64]  I. Mattaj,et al.  U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. , 1998, Molecular cell.

[65]  M. Calzado,et al.  Human Immunodeficiency Virus Type 1 Tat Increases the Expression of Cleavage and Polyadenylation Specificity Factor 73-Kilodalton Subunit Modulating Cellular and Viral Expression , 2004, Journal of Virology.

[66]  N. Sonenberg,et al.  The mRNA closed-loop model: the function of PABP and PABP-interacting proteins in mRNA translation. , 2001, Cold Spring Harbor symposia on quantitative biology.

[67]  Bin Tian,et al.  Alternative polyadenylation of cyclooxygenase-2 , 2005, Nucleic acids research.

[68]  N. Proudfoot,et al.  Recruitment of a Basal Polyadenylation Factor by the Upstream Sequence Element of the Human Lamin B2 Polyadenylation Signal , 2000, Molecular and Cellular Biology.

[69]  D. Black Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[70]  H. Grönberg,et al.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.

[71]  A. Scorilas,et al.  Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer. , 2000, Cancer research.

[72]  W. Marzluff,et al.  Introns in histone genes alter the distribution of 3' ends. , 1990, Nucleic acids research.

[73]  M. Hentze,et al.  Starting at the Beginning, Middle, and End: Translation Initiation in Eukaryotes , 1997, Cell.

[74]  Syuzo Kaneko,et al.  Terminating the transcript: breaking up is hard to do. , 2006, Genes & development.

[75]  A. Harris,et al.  Prevalence of common mutations in the arylsulphatase A gene in metachromatic leukodystrophy patients diagnosed in Britain , 1993, Human Genetics.

[76]  L. Tong,et al.  Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease , 2006, Nature.

[77]  R. Sandri-Goldin,et al.  A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing. , 1992, Genes & development.

[78]  I. Kanazawa,et al.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy , 1998, Nature.

[79]  K. von Figura,et al.  Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[80]  F C Kafatos,et al.  Amplification and characterization of a beta-globin gene synthesized in vitro. , 1976, Cell.

[81]  E. Wahle,et al.  Structure and function of poly(A) binding proteins. , 2004, Biochimica et biophysica acta.

[82]  H. Shin,et al.  Polymorphisms in fatty acid-binding protein-3 (FABP3) - putative association with type 2 diabetes mellitus. , 2003, Human mutation.

[83]  S. Orkin,et al.  Thalassemia due to a mutation in the cleavage‐polyadenylation signal of the human beta‐globin gene. , 1985, The EMBO journal.

[84]  D. Shweiki,et al.  A novel function for alternative polyadenylation as a rescue pathway from NMD surveillance. , 2007, Biochemical and biophysical research communications.

[85]  B. Blencowe,et al.  An Evolutionarily Conserved Role for SRm160 in 3′-End Processing That Functions Independently of Exon Junction Complex Formation* , 2003, Journal of Biological Chemistry.

[86]  J. McLauchlan,et al.  Herpes simplex virus induces a processing factor that stimulates poly(A) site usage , 1989, Cell.

[87]  B. Coupar,et al.  A common mechanism for the synthesis of membrane and secreted immunoglobulin α, γ and μ chains , 1982, Nature.

[88]  R. Compans,et al.  Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. , 1971, Virology.

[89]  M. Hentze,et al.  The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. , 2004, Blood.

[90]  S. Jacob,et al.  Antibodies against nuclear poly(A) polymerases in rheumatic autoimmune diseases , 2004, Journal of Clinical Immunology.

[91]  C. Shin,et al.  Cell signalling and the control of pre-mRNA splicing , 2004, Nature Reviews Molecular Cell Biology.

[92]  C. C. Spaargaren-van Riel,et al.  G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′‐end formation , 2004, Journal of thrombosis and haemostasis : JTH.

[93]  M. Hentze,et al.  Nonsense-mediated decay approaches the clinic , 2004, Nature Genetics.

[94]  S. Akman,et al.  NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. , 1995, Cancer research.

[95]  D. Rubinsztein,et al.  Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. , 2006, Human molecular genetics.

[96]  K. Venkataraman,et al.  Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition. , 2005, Genes & development.

[97]  Michael Hampsey,et al.  Tails of Intrigue Phosphorylation of RNA Polymerase II Mediates Histone Methylation , 2003, Cell.

[98]  S. Reis,et al.  Genetic Variation in Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 (LOX1) Gene and the Risk of Coronary Artery Disease , 2003, Circulation.

[99]  R. Russell,et al.  Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3′UTR Evolution , 2005, Cell.

[100]  M. Wollerton,et al.  Upstream sequence elements enhance poly(A) site efficiency of the C2 complement gene and are phylogenetically conserved. , 1995, The EMBO journal.

[101]  A. Schambach,et al.  Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[102]  Shun–ichi Kobayashi Tokyo campus rising , 1998, Nature.

[103]  Hans D. Ochs,et al.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome , 2001, Immunogenetics.

[104]  C. Langefeld,et al.  Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression. , 2003, Kidney international.

[105]  I. Mattaj,et al.  The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. , 2000, Genes & development.

[106]  R. Desnick,et al.  Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[107]  A. Furger,et al.  Integrating mRNA Processing with Transcription , 2002, Cell.

[108]  R. Krug,et al.  The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. , 2001, RNA.

[109]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[110]  M. Philippe,et al.  Poly(A)-Binding Protein Acts in Translation Termination via Eukaryotic Release Factor 3 Interaction and Does Not Influence [PSI+] Propagation , 2002, Molecular and Cellular Biology.

[111]  A. Jacobson,et al.  Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression , 2003, Genome Biology.

[112]  Ed Hurt,et al.  A Conserved mRNA Export Machinery Coupled to pre-mRNA Splicing , 2002, Cell.

[113]  L. Minvielle-Sebastia,et al.  mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. , 1999, Current opinion in cell biology.

[114]  S. DeKosky,et al.  Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease , 2003, Journal of medical genetics.

[115]  W. Keller,et al.  Human Fip1 is a subunit of CPSF that binds to U‐rich RNA elements and stimulates poly(A) polymerase , 2004, The EMBO journal.

[116]  S. Jacob,et al.  Polyadenylate polymerases from normal and cancer cells and their potential role in messenger RNA processing: a review. , 1989, Cancer research.

[117]  B. Tian,et al.  Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. , 2005, RNA.

[118]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[119]  M. Spitz,et al.  Thymidylate Synthase 5′- and 3′-Untranslated Region Polymorphisms Associated with Risk and Progression of Squamous Cell Carcinoma of the Head and Neck , 2004, Clinical Cancer Research.

[120]  J. Steitz,et al.  Symplekin and multiple other polyadenylation factors participate in 3'-end maturation of histone mRNAs. , 2005, Genes & development.

[121]  Lung-Ji Chang,et al.  RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy , 2002, Journal of Virology.

[122]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[123]  J. Manley,et al.  RNA polymerase II and the integration of nuclear events. , 2000, Genes & development.

[124]  D. Gautheret,et al.  Sequence determinants in human polyadenylation site selection , 2003, BMC Genomics.

[125]  M. Wickens,et al.  Poly (A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early development. , 1995, RNA.

[126]  J. Zehnder,et al.  Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. , 2003, The Journal of molecular diagnostics : JMD.

[127]  E. Wahle,et al.  The mechanism of 3' cleavage and polyadenylation of eukaryotic pre-mRNA. , 1997, Progress in nucleic acid research and molecular biology.

[128]  J. Gelfand,et al.  Generation of a tropoelastin mRNA variant by alternative polyadenylation site selection in sun-damaged human skin and ultraviolet B-irradiated fibroblasts. , 1998, Biochemical and biophysical research communications.

[129]  G. Utermann,et al.  The 342‐kb deletion in GJB6 is not present in patients with non‐syndromic hearing loss from Austria , 2003, Human mutation.

[130]  C. McGuigan,et al.  A nuclear cap-binding complex facilitates association of U1 snRNP with the cap-proximal 5' splice site. , 1996, Genes & development.

[131]  G. Bouma,et al.  A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion , 2002, Genes and Immunity.

[132]  J. Manley,et al.  Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. , 1998, Molecular cell.

[133]  Tyra Hall-Pogar,et al.  Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR. , 2007, RNA.

[134]  Sita Awasthi,et al.  Association of polyadenylation cleavage factor I with U1 snRNP. , 2003, RNA.

[135]  H. Moses,et al.  Effect of cell proliferation on levels and diversity of poly(A)-containing mRNA , 1976, Cell.

[136]  S. Goodbourn,et al.  Alpha-thalassaemia caused by a polyadenylation signal mutation. , 1983, Nature.

[137]  S. Gunderson,et al.  Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA , 2001, The EMBO journal.

[138]  J. Houwing-Duistermaat,et al.  Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. , 2005, Blood.

[139]  T. Marr,et al.  Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. , 2005, Genome research.

[140]  J. Rogers,et al.  Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain , 1980, Cell.

[141]  S. Thein,et al.  Detection of prothrombin gene polymorphism at position 20209 (PT20209C/T): Pilot study in a black population in the United Kingdom , 2005, Thrombosis and Haemostasis.

[142]  B. Blencowe,et al.  SRm160 Splicing Coactivator Promotes Transcript 3′-End Cleavage , 2002, Molecular and Cellular Biology.

[143]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[144]  T. Tsukahara,et al.  The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. , 2001, Human molecular genetics.

[145]  Y. Miura,et al.  Polyadenylic acid polymerase activity in chronic myelogenous leukemia. , 1990, Leukemia research.

[146]  C. Langefeld,et al.  Association of an IL-1A 3′UTR polymorphism with end-stage renal disease and IL-1α expression , 2003 .

[147]  A. Scorilas Polyadenylate Polymerase (PAP) and 3' End pre-mRNA Processing: Function, Assays, and Association with Disease , 2002, Critical reviews in clinical laboratory sciences.

[148]  L. Paillard,et al.  AU-rich elements and associated factors: are there unifying principles? , 2006, Nucleic acids research.

[149]  Anton J. Enright,et al.  Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAs , 2006, Science.

[150]  William Ritchie,et al.  Differential Repression of Alternative Transcripts: A Screen for miRNA Targets , 2006, PLoS Comput. Biol..

[151]  J. Manley,et al.  The Polyadenylation Factor CstF-64 Regulates Alternative Processing of IgM Heavy Chain Pre-mRNA during B Cell Differentiation , 1996, Cell.

[152]  B. Graveley Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.

[153]  S. Groshen,et al.  A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer , 2004, British Journal of Cancer.

[154]  David Baltimore,et al.  Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends , 1980, Cell.

[155]  C. Baker,et al.  An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels , 1991, Journal of virology.

[156]  U. Pendurthi,et al.  Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[157]  A. J. Lopez,et al.  Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. , 1998, Annual review of genetics.

[158]  L. Maquat Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics , 2004, Nature Reviews Molecular Cell Biology.

[159]  Niseema D. Pachikara,et al.  U1A Inhibits Cleavage at the Immunoglobulin M Heavy-Chain Secretory Poly(A) Site by Binding between the Two Downstream GU-Rich Regions , 2004, Molecular and Cellular Biology.

[160]  Y. Xia,et al.  Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. , 1993, Archives of biochemistry and biophysics.

[161]  R. Bertina,et al.  Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio , 2007 .

[162]  Peter Marynen,et al.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. , 2003, The New England journal of medicine.

[163]  B. Brais,et al.  Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. , 2000, Human molecular genetics.

[164]  W. Keller,et al.  An interaction between U2AF 65 and CF Im links the splicing and 3′ end processing machineries , 2006, The EMBO journal.

[165]  R. Kraaijenhagen,et al.  Clinical Expression of a Rare β-Globin Gene Mutation Co-Inherited with Haemoglobin E-Disease , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[166]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[167]  Kirk M Brown,et al.  A mechanism for the regulation of pre-mRNA 3' processing by human cleavage factor Im. , 2003, Molecular cell.

[168]  M. Hentze,et al.  Nonsense-mediated mRNA decay: from vacuum cleaner to Swiss army knife , 2004, Genome Biology.

[169]  C. Kattamis,et al.  Two novel polyadenylation mutations leading to β+‐thalassaemia , 1990 .

[170]  William F Marzluff,et al.  Metazoan replication-dependent histone mRNAs: a distinct set of RNA polymerase II transcripts. , 2005, Current opinion in cell biology.

[171]  S. Rose,et al.  In vitro polyadenylation is stimulated by the presence of an upstream intron. , 1990, Genes & development.

[172]  C. Prives,et al.  Cell-cycle related regulation of poly(A) polymerase by phosphorylation , 1996, Nature.

[173]  Hua-Lin Zhou,et al.  Hu Proteins Regulate Polyadenylation by Blocking Sites Containing U-rich Sequences* , 2007, Journal of Biological Chemistry.

[174]  B. Coupar,et al.  A common mechanism for the synthesis of membrane and secreted immunoglobulin alpha, gamma and mu chains. , 1982, Nature.

[175]  C. Milcarek,et al.  Elevated Levels of the 64-kDa Cleavage Stimulatory Factor (CstF-64) in Lipopolysaccharide-stimulated Macrophages Influence Gene Expression and Induce Alternative Poly(A) Site Selection* , 2005, Journal of Biological Chemistry.

[176]  J. Rommens,et al.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.

[177]  R. Bertina,et al.  Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio. , 2007, Journal of thrombosis and haemostasis : JTH.

[178]  J. Wilusz,et al.  hnRNP F Influences Binding of a 64-Kilodalton Subunit of Cleavage Stimulation Factor to mRNA Precursors in Mouse B Cells , 2001, Molecular and Cellular Biology.

[179]  K. Ryan,et al.  Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease. , 2004, RNA.

[180]  A. Phelan,et al.  Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch , 1996, Journal of virology.

[181]  Marieke,et al.  Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene , 1992, Molecular and cellular biology.

[182]  J. Manley,et al.  Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. , 1999, Science.

[183]  B. Dallapiccola,et al.  An ATG repeat in the 3'-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. , 2002, The Journal of clinical endocrinology and metabolism.

[184]  A. Shyu,et al.  The Double Lives of Shuttling mRNA Binding Proteins , 2000, Cell.

[185]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[186]  Matthias W. Hentze,et al.  Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia , 2001, Nature Genetics.

[187]  B. Graveley,et al.  CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition. , 1995, Genes & development.

[188]  P. Klenerman,et al.  Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection , 2002, Genes and Immunity.

[189]  B. Kosova,et al.  Budd–Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene , 2003, Journal of thrombosis and haemostasis : JTH.

[190]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[191]  M. Hentze,et al.  A Perfect Message RNA Surveillance and Nonsense-Mediated Decay , 1999, Cell.

[192]  D. Bell,et al.  Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. , 1995, Cancer research.

[193]  K. Mui,et al.  Nuclear polyadenylate polymerase activity in the brain of seizure‐prone EL mice , 1997, Psychiatry and clinical neurosciences.

[194]  Bharat Gawande,et al.  Drosophila Sex‐lethal protein mediates polyadenylation switching in the female germline , 2006, The EMBO journal.

[195]  M. Lotze,et al.  Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[196]  D. J. Weatherall,et al.  Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias , 2001, Nature Reviews Genetics.

[197]  R. Krug,et al.  The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. , 1994, Genes & development.

[198]  I. Mattaj,et al.  Involvement of the carboxyl terminus of vertebrate poly(A) polymerase in U1A autoregulation and in the coupling of splicing and polyadenylation. , 1997, Genes & development.

[199]  A. Beloso,et al.  Influenza virus NS1 protein inhibits pre‐mRNA splicing and blocks mRNA nucleocytoplasmic transport. , 1994, The EMBO journal.

[200]  T. Huisman,et al.  Two novel polyadenylation mutations leading to beta(+)-thalassemia. , 1990, British journal of haematology.

[201]  B. Dunn Computational Analysis , 2007 .

[202]  W. Guo,et al.  Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. , 2004, Carcinogenesis.

[203]  A. Weiner,et al.  E Pluribus Unum: 3' end formation of polyadenylated mRNAs, histone mRNAs, and U snRNAs. , 2005, Molecular cell.

[204]  G. Edwalds-Gilbert,et al.  Alternative poly(A) site selection in complex transcription units: means to an end? , 1997, Nucleic acids research.

[205]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[206]  L. Minvielle-Sebastia,et al.  A comparison of mammalian and yeast pre-mRNA 3'-end processing. , 1997, Current opinion in cell biology.

[207]  Jeffrey Wilusz,et al.  Upstream Elements Present in the 3′-Untranslated Region of Collagen Genes Influence the Processing Efficiency of Overlapping Polyadenylation Signals* , 2002, The Journal of Biological Chemistry.

[208]  L. Wolpert Developmental Biology , 1968, Nature.

[209]  M. Buchwald,et al.  Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9 , 1992, Nature Genetics.

[210]  R. Desnick,et al.  Fabry disease: novel alpha-galactosidase A 3'-terminal mutations result in multiple transcripts due to aberrant 3'-end formation. , 2003, American journal of human genetics.

[211]  M. Wollerton,et al.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms. , 1998, Genes & development.